{'52WeekChange': 0.805567,
 'SandP52WeekChange': 0.0644362,
 'address1': '3611 Valley Centre Drive',
 'address2': 'Suite 300',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 43.3,
 'askSize': 800,
 'averageDailyVolume10Day': 2781425,
 'averageVolume': 1758549,
 'averageVolume10days': 2781425,
 'beta': 1.798319,
 'beta3Year': None,
 'bid': 43.25,
 'bidSize': 900,
 'bookValue': 4.107,
 'category': None,
 'circulatingSupply': None,
 'city': 'San Diego',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 43.89,
 'dayLow': 42.85,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -24.922,
 'enterpriseToRevenue': 16.728,
 'enterpriseValue': 6125362688,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fax': '858 558 2872',
 'fiftyDayAverage': 50.101715,
 'fiftyTwoWeekHigh': 58.72,
 'fiftyTwoWeekLow': 23.13,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 113549345,
 'forwardEps': -0.52,
 'forwardPE': -83.57693,
 'fromCurrency': None,
 'fullTimeEmployees': 550,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.00099,
 'heldPercentInstitutions': 0.97571,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/acadia-pharm.com',
 'longBusinessSummary': 'ACADIA Pharmaceuticals Inc., a biopharmaceutical '
                        'company, focuses on the development and '
                        'commercialization of small molecule drugs that '
                        'address unmet medical needs in central nervous system '
                        'disorders. The company offers NUPLAZID (pimavanserin) '
                        'for the treatment of hallucinations and delusions '
                        "associated with Parkinson's disease psychosis. It is "
                        'also developing pimavanserin as a treatment for '
                        'dementia-related psychosis and as an adjunctive '
                        'treatment for schizophrenia that are in Phase III '
                        'clinical trials; and pimavanserin as an adjunctive '
                        'treatment for major depressive disorder. ACADIA '
                        'Pharmaceuticals Inc. was founded in 1993 and is '
                        'headquartered in San Diego, California.',
 'longName': 'ACADIA Pharmaceuticals Inc.',
 'market': 'us_market',
 'marketCap': 6773718528,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_683713',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -237978000,
 'nextFiscalYearEnd': 1640908800,
 'open': 43.2,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.94,
 'phone': '858 558 2871',
 'previousClose': 43.75,
 'priceHint': 2,
 'priceToBook': 10.581933,
 'priceToSalesTrailing12Months': 18.498077,
 'profitMargins': -0.64988,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 43.89,
 'regularMarketDayLow': 42.85,
 'regularMarketOpen': 43.2,
 'regularMarketPreviousClose': 43.75,
 'regularMarketPrice': 43.2,
 'regularMarketVolume': 1371079,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 155860992,
 'sharesPercentSharesOut': 0.063,
 'sharesShort': 9819101,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 11225120,
 'shortName': 'ACADIA Pharmaceuticals Inc.',
 'shortPercentOfFloat': 0.111499995,
 'shortRatio': 4.67,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ACAD',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.586,
 'twoHundredDayAverage': 45.58331,
 'volume': 1371079,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.acadia-pharm.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92130'}